In the present study, we define the relation between
TGF-beta and
IL-10 in the regulation of the Th1-mediated
inflammation occurring in trinitrobenzene
sulfonic acid (TNBS)-
colitis. In initial studies, we showed that the feeding of
trinitrophenol-haptenated colonic
protein to SJL/J mice induces CD4(+) regulatory T cells that transfer protection from induction of TNBS-
colitis, and that such protection correlates with cells producing
TGF-beta, not
IL-10. Further studies in which SJL/J mice were fed haptenated colonic
protein, and then administered either anti-
TGF-beta or anti-IL-10 at the time of subsequent TNBS administration per rectum, showed that while both Abs abolished protection, anti-
TGF-beta administration prevented
TGF-beta secretion, but left
IL-10 secretion intact; whereas anti-IL-10 administration prevented both
TGF-beta secretion and
IL-10 secretion. Thus, it appeared that the protective effect of
IL-10 was an indirect consequence of its effect on
TGF-beta secretion. To establish this point further, we conducted adoptive transfer studies and showed that anti-IL-10 administration had no effect on induction of
TGF-beta producing T cells in donor mice. However, it did inhibit their subsequent expansion in recipient mice, probably by regulating the magnitude of the Th1 T cell response which would otherwise inhibit the
TGF-beta response. Therefore, these studies suggest that
TGF-beta production is a primary mechanism of counter-regulation of Th1 T cell-mediated mucosal
inflammation, and that
IL-10 is necessary as a secondary factor that facilitates
TGF-beta production.